info@srobf.cz +420 495 832 176
CZ / EN
Pro odborníky

TOP TEN ASTRO 2012

1. Radiation Therapy Protocol Deviations are Associated With Inferior Clinical Outcomes

2. Final Analysis of Intergroup Randomized Phase III Study of Androgen Deprivation Therapy ± Radiation Therapy in Locally Advanced Prostate Cancer

3. Low-risk Breast Ductal Carcinoma In Situ (DCIS)_ Results From the Radiation Therapy Oncology Group 9804 Phase 3 trial

4. RTOG 90-03 Final Report

5. Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma 10-year Update of the HD8 Trial of the GHSG

6. Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients with Locally Advanced Non-small Cell Lung Cancer – An Updated Analysis of RTOG 0214

7. Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT) First Report of RTOG 0614

8. Results of a Prospective Randomized Double-blind, Placebo controlled Trial Evaluating the Use of Prophylactic Sildenafil Citrate During Radiation Therapy in the Treatment of Prostate Cancer

9. Radium-223 Chloride Safety and Use of EBRT in the Phase III Randomized Trial (ALSYMPCA) in Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases

10. Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233

Významné metaanalýzy

Identification of Comorbidities That Place Men at Highest Risk of Harm From Androgen Deprivation Therapy for Prostate Cancer

Improved Survival With Adjuvant Radiation in Elderly Women With Early-stage Breast Cancer

Prognostic Significance of Number of +LNs in Women With T1-2N1 Breast Cancer Treated With Mastectomy

Proton Radiation Therapy for Prostate Cancer in the Medicare Population_Patterns of Care and Comparison of Early Toxicity With IMRT

Radical Cystectomy (RC) Versus Bladder Preservation Therapy (BPT) for Muscle-invasive Bladder Cancer

Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment

Stage I and II Endometrial Adenocarcinoma_ Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy

Treatment Patterns and Locoregional Recurrence Outcomes in Patients with pN0(i+) Breast Cancer

Twenty-year Competing Risk Analysis of Secondary Malignancies After EBRT for Postoperative Treatment of Prostate Cancer Patients From the SEER Database

Who Dies From Prostate Cancer_ An Analysis of the SEER Database

6